Stay updated on Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial page.

Latest updates to the Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial page
- Check7 days agoChange DetectedThe page's metadata now shows ovarian cancer as a related topic and links to MedlinePlus Genetics, and the site revision has been updated from v3.6.5 to v3.6.6.SummaryDifference0.2%

- Check14 days agoChange DetectedAn NIH funding attribution line '2016 ( U.S. NIH Grant/Contract )' was added to the study listing. Related-topic tags 'Ovarian cancer' and 'MedlinePlus Genetics' were removed from the MedlinePlus related topics.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, signaling a newer version of the page. This update is metadata-related and does not modify the study details or content.SummaryDifference0.0%

- Check42 days agoChange DetectedThe page shows a new revision label indicating v3.6.4 has been published. This update does not modify the study data or study details displayed on the page.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, indicating a minor update to the entry. This update does not modify the study data or eligibility criteria.SummaryDifference0.0%

- Check71 days agoChange DetectedRevision label on the page was updated to v3.6.2, replacing the previous v3.6.0, indicating a minor backend or documentation update rather than changes to study data or visible content.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial page.